Deutsch Barry M. 4
4 · XERIS PHARMACEUTICALS INC · Filed Jul 3, 2019
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Award
Common Stock
2019-07-01$9.72/sh+1,428$13,880→ 29,720 total
Footnotes (2)
- [F1]These shares were purchased due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from January 1, 2019 through June 30, 2019.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019.